Cargando…

A candidate gene investigation of methylphenidate response in adult attention-deficit/hyperactivity disorder patients: results from a naturalistic study

Attention-deficit/hyperactivity disorder (ADHD) is a common childhood onset neuropsychiatric disorder with a complex and heterogeneous symptomatology. Persistence of ADHD symptoms into adulthood is common. Methylphenidate (MPH) is a widely prescribed stimulant compound that may be effective against...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hegvik, Tor-Arne, Jacobsen, Kaya Kvarme, Fredriksen, Mats, Zayats, Tetyana, Haavik, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2016
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969350/ https://www.ncbi.nlm.nih.gov/pubmed/27091191 http://dx.doi.org/10.1007/s00702-016-1540-7

Ejemplares similares

Druggable genome in attention deficit/hyperactivity disorder and its co-morbid conditions. New avenues for treatment
por: Hegvik, Tor-Arne, et al.
Publicado: (2019)

Autoantibodies targeting neurotransmitter biosynthetic enzymes in attention-deficit/hyperactivity disorder (ADHD)
por: Hegvik, Tor-Arne, et al.
Publicado: (2013)

Therapeutic drug monitoring of atomoxetine in children and adolescents with attention-deficit/ hyperactivity disorder: a naturalistic study
por: Ruppert, Katrin, et al.
Publicado: (2022)

Driving and attention deficit hyperactivity disorder
por: Fuermaier, Anselm B. M., et al.
Publicado: (2015)

Sex differences in parent–offspring recurrence of attention‐deficit/hyperactivity disorder
por: Solberg, Berit S., et al.
Publicado: (2020)

Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study
por: Hegvik, Tor-Arne, et al.
Publicado: (2017)

Correction to: Associations between attention-deficit/hyperactivity disorder and autoimmune diseases are modified by sex: a population-based cross-sectional study
por: Hegvik, Tor-Arne, et al.
Publicado: (2017)

Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review
por: Dinu, Larisa Maria, et al.
Publicado: (2022)

Atypical resting-state gamma band trajectory in adult attention deficit/hyperactivity disorder
por: Tombor, László, et al.
Publicado: (2021)

Attention-deficit/hyperactivity disorder and smoking habits in pregnant women
por: Andersson, Anneli, et al.
Publicado: (2020)

Serum concentrations of kynurenines in adult patients with attention-deficit hyperactivity disorder (ADHD): a case–control study
por: Aarsland, Tore Ivar Malmei, et al.
Publicado: (2015)

Long-term changes in serum levels of lipoproteins in children and adolescents with attention-deficit/hyperactivity disorder (ADHD)
por: Huber, Franziska, et al.
Publicado: (2023)

Moderating effect of mode of delivery on the genetics of intelligence: Explorative genome‐wide analyses in ALSPAC
por: Smajlagić, Dinka, et al.
Publicado: (2018)

Electrophysiological underpinnings of dysfunctional inhibitory control in adults with attention-deficit/hyperactivity disorder: evidence for reduced NoGo anteriorization
por: Papp, Szilvia, et al.
Publicado: (2023)

The impact of preschool child and maternal attention-deficit/hyperactivity disorder (ADHD) symptoms on mothers’ perceived chronic stress and hair cortisol
por: Szép, Anna, et al.
Publicado: (2021)

Norepinephrine influences the circadian clock in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Palm, Denise, et al.
Publicado: (2021)

Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder
por: Faltraco, Frank, et al.
Publicado: (2021)

Adult attention-deficit/hyperactivity disorder symptoms, cognitive dysfunction and quality of life in high-dose use of benzodiazepine and Z-drug
por: Federico, Angela, et al.
Publicado: (2020)

Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
por: Grünblatt, Edna, et al.
Publicado: (2019)

Methylphenidate use in children with attention deficit hyperactivity disorder
por: Machado, Felipe Salles Neves, et al.
Publicado: (2015)

Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
por: Yde Ohki, Cristine Marie, et al.
Publicado: (2023)

Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study
por: Chen, Qi, et al.
Publicado: (2018)

Familial co-aggregation of attention-deficit/hyperactivity disorder and autoimmune diseases: a cohort study based on Swedish population-wide registers
por: Hegvik, Tor-Arne, et al.
Publicado: (2021)

Patterns of Psychiatric Comorbidity and Genetic Correlations Provide New Insights Into Differences Between Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder
por: Solberg, Berit S., et al.
Publicado: (2019)

The Effects of Methylphenidate on Decision Making in Attention-Deficit/Hyperactivity Disorder
por: DeVito, Elise E., et al.
Publicado: (2008)

The Effect of Methylphenidate on the Hearing of Children with Attention Deficit Hyperactivity Disorder
por: İsmi, Onur, et al.
Publicado: (2018)

The Association Between Attention-Deficit Hyperactivity Disorder, Injuries, and Methylphenidate
por: Shem-Tov, Sharon, et al.
Publicado: (2019)

New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder
por: Pitzianti, Maria Bernarda, et al.
Publicado: (2020)

Individualizing the dosage of Methylphenidate in children with attention deficit hyperactivity disorder
por: Shirafkan, Hoda, et al.
Publicado: (2020)

Shifting uncertainty intolerance: methylphenidate and attention-deficit hyperactivity disorder
por: Mandali, Alekhya, et al.
Publicado: (2021)

Pica in an Adolescent with Attention Deficit Hyperactivity Disorder responsive to Methylphenidate
por: Bourgou, Soumaya, et al.
Publicado: (2021)

Continuity in Methylphenidate Treatment of Adults With Attention-Deficit/Hyperactivity Disorder
por: Olfson, Mark, et al.
Publicado: (2007)

Genome-Wide Analysis of Attention Deficit Hyperactivity Disorder in Norway
por: Zayats, Tetyana, et al.
Publicado: (2015)

Comparison of the effects of methylphenidate and the combination of methylphenidate and risperidone in preschool children with attention-deficit hyperactivity disorder
por: Safavi, Parvin, et al.
Publicado: (2016)

Recent advances in understanding of attention deficit hyperactivity disorder (ADHD): how genetics are shaping our conceptualization of this disorder
por: Zayats, Tetyana, et al.
Publicado: (2020)

Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Nair, Rajasree, et al.
Publicado: (2009)

The Safety and Efficacy of Methylphenidate and Dexmethylphenidate in Adults with Attention Deficit/Hyperactivity Disorder
por: Sopko, Michael A., et al.
Publicado: (2010)

Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS)
por: Findling, Robert L., et al.
Publicado: (2014)

Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder
por: Pagerols, Mireia, et al.
Publicado: (2018)

Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
por: Jaeschke, Rafał R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8b0pdujed4lqe6dmfevmhmno2j